Some ratings on this page are entered from the public AllSides ratings and not yet verified against the licensed feed.
Pharmacy issues nationwide recall of compounded injectable products
What happened
Apothecary Pharma issued a nationwide recall of 23 compounded injectable drug vials. The FDA classified the recall as Class II. The pharmacy had previously received a warning from the FDA.
Side by side
USA Today emphasizes consumer safety in its framing, asking "Is yours safe?" in one headline and directing readers to "See affected products" in another.
- USACompounded GLP-1 injections recalled nationwide. Is yours safe?USA Today · Lean Left · link via Google News
- USAGLP-1 injections recalled nationwide. See affected productsUSA Today · Lean Left · link via Google News
The Hill and Reuters focus on different aspects, with The Hill noting the products are "not FDA-approved nor name-brand" while Reuters runs an exclusive story on Dr Reddy's introducing "new generic Ozempic brands" in response to supply issues.
- HILNationwide recall on these compound GLP-1 drugsThe Hill · Center
- RTREXCLUSIVE: Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruptionReuters · Center · link via Google News
Fox Business and New York Post both highlight that the company "previously received a warning," with Fox Business specifying the warning concerned "sterile drug production" and noting "sterility concerns" as the recall reason.
- FBNGLP-1 injections recalled nationwide over sterility concernsFox Business · Lean Right
- NYPGLP-1 injections recalled nationwide — what to know about the affected productsNew York Post · Right
Bias ratings from AllSides Media Bias Ratings™. Ratings are fluid and change as outlets change. Unbiased links to the source article rather than reproducing it. A few outlets no longer publish a feed and reach us through Google News; their links are marked, and they pass through Google before reaching the outlet.